Trials / Sponsors / Bionoxx Inc.
Bionoxx Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients Treatment-Refractory Solid Tumors | Phase 1 | 2027-01-01 |
| Recruiting | A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients Treatment-Refractory Solid Tumors | Phase 1 | 2026-03-09 |
| Completed | A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experimen Healthy Volunteer | EARLY_Phase 1 | 2022-01-04 |